Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Shane McClanahan

Could The Rays Still Move A Starting Pitcher?

By | at

The Rays entered the offseason with at least seven rotation-caliber arms on the roster. Each of Shane McClanahan, Taj Bradley, Drew Rasmussen, Zack Littell, Shane Baz, Jeffrey Springs and Ryan Pepiot has had success in a big league rotation, though injuries have hobbled several of that group in recent years. Tampa Bay already thinned out that stock of arms (and, naturally, trimmed payroll) by shipping Springs and lefty Jacob Lopez to the A’s in a deal netting them righty Joe Boyle, minor leaguers Will Simpson and Jacob Watters, and a Competitive Balance (Round A) draft pick in 2025.

The Rays now have “only” six starters with proven (to varying levels) track records in the majors. Marc Topkin of the Tampa Bay Times writes that they’re still planning on a five-man rotation, however, adding that trading a starter in the late stages of spring training is “not out of the question.” At best, that very lightly leaves the door for a trade propped open. There’s nothing to strongly suggest the Rays are planning to deal from the rotation. Still, it’s nonetheless worth examining the team’s options if it comes to that point.

The veteran Littell would be the most obvious candidate to change hands. Tampa Bay moved the now-29-year-old righty from the bullpen to the rotation midway through the 2023 season, and the results have been better than anyone could’ve reasonably predicted. Littell solidified the staff in the second half of ’23 and pitched a career-high 156 1/3 innings with a 3.63 ERA over 29 starts last season. Since moving to a starting role after the Rays claimed him from the Red Sox, Littell has started 40 games and logged a combined 3.65 ERA with a lower-than-average 20.4% strikeout rate but a sensational 4.1% walk rate.

Each of the Rays’ other starting pitchers is signed or controlled via arbitration through at least the 2027 season. Littell is a free agent following the 2025 campaign. He’s being paid a reasonable $5.72MM. He’s not an ace by any stretch of the imagination, but based on how he’s fared since July 2023, the right-hander could step into the third, fourth or fifth spot in most big league rotations.

Trading anyone from the rest of the group is tougher to envision. McClanahan has pitched at a Cy Young level when healthy but missed all of 2024 recovering from Tommy John surgery. He’s controlled through 2027. Moving him right now would mean moving their most talented starter at a time when they’d be selling low. Rasmussen signed a two-year deal with a club option earlier this offseason. That bought out his remaining arbitration seasons and gave Tampa Bay control over his first free-agent year by way of that 2027 club option. Flipping him so soon after signing him to that deal is extremely difficult to envision; MLB teams simply don’t sign a player to extension and then trade him prior to ever appearing in their jersey under the terms of that new contract.

Baz and Pepiot are under club control through 2028. The former is earning $1.45MM in 2025, while the latter has yet to reach arbitration. (Baz did so as a Super Two player.) Bradley can’t become a free agent until the 2029-30 offseason. We’re talking about the Rays, so the “never say never” caveat always applies to some extent, but acquiring four or five seasons of anyone from that bucket would very likely come at a steep price and require a team to part with MLB-ready bats that are both high-upside and controllable for a similar or even lengthier window.

Any team even contemplating a trade from the rotation at this stage of the calendar will be wary, of course. As we’ve seen throughout the league — most prominently up in the Bronx — perceived starting pitching “surpluses” can turn into deficits quickly this time of year. The Rays won’t move someone just to trim payroll, but they have depth even beyond the six arms mentioned here.

The previously mentioned Boyle, for instance, is having a nice spring and has experience in a big league rotation already. Following his acquisition in the Springs trade, president of baseball operations Erik Neander called the 6’7″ righty someone who has “the physicality and the stuff to fit at the front of the rotation.” Boyle averages nearly 98 mph on his heater but has severe command issues that need to be ironed out. Righty Jacob Waguespack might be Triple-A bound but has 105 2/3 big league innings under his belt. Prospects Joe Rock and Ian Seymour both had some success in Triple-A last year (the latter in particular). There’s no such thing as “too much” rotation depth, but that group could further embolden the Rays to listen on Littell or another big league starter if a team makes a compelling offer.

Rays Sign Phil Maton

By | at

The Rays bulked up their bullpen Wednesday, finalizing their previously reported one-year contract with free agent righty Phil Maton.  The Paragon Sports International client is reportedly guaranteed $6.5MM, which takes the form of a $6.25MM salary and a $250K buyout on a $7.75MM club option for the 2025 season.  Tampa Bay transferred left-hander Shane McClanahan, who’s recovering from Tommy John surgery, to the 60-day IL to open a spot for Maton on the 40-man roster.

The Cardinals, Phillies, and Yankees have been linked to Maton’s market this winter, but the reliever will now head to Tampa Bay as he enters his age-31 season.  Maton has seven years of MLB experience, breaking into the big leagues with San Diego in 2017 and then landing in Cleveland and Houston.  Maton had a 4.76 ERA over 215 1/3 innings in the 2017-21 seasons, but a 3.68 ERA in that same span and excellent spin rates and soft-contact numbers indicated that the ceiling was higher on the righty’s performance.

The results began to show over Maton’s last two seasons, both with the Astros.  He delivered a 3.84 ERA in 65 2/3 innings in 2022 and then followed up even more strongly with a 3.00 ERA over 66 frames this past year.  As per Statcast, Maton had the second-best hard-hit ball rate of any qualified pitcher in baseball in 2023, and the spin rates on his curveball and fastball were both in at least the 98th percentile of all pitchers.

Walks have been an issue for Maton, and his above-average but not standout barrel rates indicate that batters can hit for power on the rare occasions when they actually make solid contact on Maton’s offerings.  Still, between his ability to generate soft contact and his above-average strikeout rates, Maton has rather quietly been one of the more effective relievers in baseball over the last two seasons.  This success has also extended into the postseason, as while injuries forced Maton to miss the Astros’ 2022 World Series run, he has a sparking 0.83 ERA over 21 2/3 career playoff innings.

Given the Rays’ success at helping pitchers achieve higher levels of performance, it wouldn’t be at all surprising to see Maton at least continue or even improve on his strong numbers from 2022-23.  Maton figures to essentially act as the replacement for Robert Stephenson, a reclamation project-turned-high leverage reliever after joining the Rays last summer.

Stephenson parlayed his spectacular four-month run in Tampa into a three-year, $33MM free agent deal with the Angels.  Jake Diekman also signed with the Mets, Andrew Kittredge was traded to the Cardinals, and Jalen Beeks and Josh Fleming were both let go at the start of free agency, leaving the Rays with some holes to fill in the relief corps.  Pete Fairbanks figures to be the team’s primary closer again, and though the Rays are traditionally pretty flexible with their bullpen roles, Maton will likely stick to set-up duty since he has only one career save.

According to Roster Resource, Tampa Bay has a projected $93.3MM payroll, which would already be the highest payroll in Rays franchise history even before Maton’s deal is added to the tally.  President of baseball operations Erik Neander said in October that the club was open to spending at a (comparatively) higher level to help keep their core in place and to make a deeper playoff run, though the Rays did move Tyler Glasnow and his $25MM salary to the Dodgers in a trade.

MLB.com’s Mark Feinsand first reported the two sides were nearing a deal (via X). Robert Murray of FanSided reported (on X) the terms of the deal, while Ari Alexander of KPRC 2 reported the specific year-to-year breakdown (X link).

Rays, Shane McClanahan Agree To Two-Year Deal

By | at

The Rays have agreed to a two-year, $7.2MM contract with ace Shane McClanahan, reports Robert Murray of FanSided. It’ll buy out the left-hander’s first two seasons of arbitration. McClanahan, who underwent Tommy John surgery in August, will spend the bulk of the contract’s first year rehabbing. He’d been projected by MLBTR contributor Matt Swartz to earn $3.6MM this coming season, based on the strength of his pre-arbitration platform. Murray adds that McClanahan’s 2025 salary will be boosted by $120K for every start he makes in 2024. The Rays can control the southpaw through the 2027 season.

McClanahan, 26, was the No. 31 overall draft pick in 2018 and has arguably surpassed even those lofty draft standards with his performance to date. Since making his MLB debut in the 2020 postseason, the southpaw has emerged as Tampa Bay’s clear top starter. From 2021-23, he logged 404 2/3 innings of 3.02 ERA ball with a 28% strikeout rate, 7.1% walk rate and 46.8% ground-ball rate.

McClanahan has averaged 97 mph on his heater in each of the past two seasons and was the sixth-place finisher in 2022 Cy Young voting in the American League. Were it not for a shoulder impingement that cost him three weeks late in the 2022 season, McClanahan might’ve had a legitimate chance at winning the award — or at least overtaking Dylan Cease as the runner-up. When he landed on the injured list, he’d pitched 147 1/3 innings with a dominant 2.20 earned run average, a massive 32.5% strikeout rate and a 5.4% walk rate. Upon returning, he stumbled with a 5.21 ERA in his final four starts, dropping him down the ballot that eventually saw Justin Verlander win the award in unanimous fashion.

In all likelihood, last August’s Tommy John surgery will keep McClanahan shelved into the 2024 season’s final month or perhaps wipe out his ’24 season entirely. He’s one of three key starters who suffered a major injury for Tampa Bay last year, joining Jeffrey Springs (Tommy John surgery) and Drew Rasmussen (internal brace surgery). That trio of injuries has depleted the Rays’ once-enviable pitching depth. Their current quintet of Zach Eflin, Aaron Civale, reliever-turned-starter Zack Littell and young righties Ryan Pepiot and Taj Bradley has plenty of upside but lacks stability (particularly when considering the injury histories of veterans Eflin and Civale). Former top prospect Shane Baz will return from his own Tommy John surgery at some point, but the Rays still seem likely to add some rotation help this winter.

As for McClanahan, he figures to be back at full strength for Opening Day 2025. In an ideal world, both he and Baz will recapture the form that made them elite pitching prospects (and, in McClanahan’s case, a two-time All-Star) and lead the starting staff for several years. McClanahan finished the 2023 season with 2.158 years of MLB service, making him a slam-dunk Super Two player and setting the stage for him to be arb-eligible four times. This two-year deal takes care of the first two of those arb years, but he’ll be eligible again both in 2026 and 2027.

Injury Notes: McClanahan, Rengifo, Kershaw, Stroman

By | at

News that Rays ace Shane McClanahan would require Tommy John surgery already strongly implied that he’ll miss not just the remainder of the 2023 season but perhaps the entire 2024 campaign as well — and McClanahan has effectively confirmed as much to Marc Topkin of the Tampa Bay Times. Topkin writes that the 26-year-old McClanahan expects to be sidelined until 2025 after renowned surgeons Dr. Neal ElAttrache and Keith Meister both made the same recommendation. Meister, who performed the procedure, also “cleaned up” some bone chips in McClanahan’s elbow, the pitcher added.

“I was really frustrated when I found out, but I can’t control that,” McClanahan tells Topkin. “…I want to control how hard I work, the quality of teammate I am and the consistency on the field. And ultimately, the next year, year and a half, whatever it may be, I’m going to work my butt off to make sure that when I’m healthy, it’s going to be the same me.” Topkin’s piece contains plenty of quotes from McClanahan on his injury, the surgery and his mindset as he embarks on a lengthy rehab process, so Rays fans in particular will want to check it out in full.

A few more injury notes from around the league…

  • Angels infielder/outfielder Luis Rengifo exited last night’s game with a strained left biceps that he apparently sustained taking swings in the on-deck circle prior to his first at-bat, per Sarah Valenzuela of the Los Angeles Times. The Angels are further evaluating him today, but manager Phil Nevin conceded that the injury “doesn’t look good.” Further details will surely follow once the 26-year-old Rengifo has undergone imaging. A Rengifo injury of note would be the latest in a series of unwelcome developments for the Angels. He’s been the team’s hottest hitter for the past six weeks, evidenced by a scalding .342/.393/.602 batting line with nine homers, nine doubles, three triples and just a 14.6% strikeout rate in that time. On the whole Rengifo is hitting .264/.339/.444 in what has easily been the most productive all-around season of his still-young career. He’s under club control for an additional two seasons beyond the current campaign.
  • Dodgers ace Clayton Kershaw still isn’t pitching at 100% following the shoulder strain that sent him to the injured list this summer, writes Fabian Ardaya of The Athletic. Kershaw didn’t reach 90 mph in his most recent start, and his average fastball velocity of just 88.4 mph in that outing was the second-lowest of any appearance in his career. Kershaw, however, is adamant that he can continue to pitch through the issue — and the Dodgers appear willing to let him do so. “If he is able to take the baseball, he’s going to take the baseball,” manager Dave Roberts said of the left-hander.
  • Marcus Stroman hasn’t pitched since July 31 due to inflammation in his hip and, more problematically, a rib cartilage fracture that was discovered as he was on the cusp of returning from that hip issue. However, he tossed 29 pitches during a live batting practice session yesterday, per Maddie Lee of the Chicago Sun-Times, and Cubs manager David Ross acknowledged that the right-hander appears to be ahead of schedule in his recovery. Stroman will likely require at least one minor league rehab start (if not two), but it seems there’s a good chance the 32-year-old could return before season’s end — and perhaps factor into the postseason rotation. How Stroman fares down the stretch will be worth watching with a particularly close eye, as he has a $21MM player option for the 2024 season but has long appeared likely to decline that and return to the market in search of a lengthier pact.

MLB Trade Rumors Podcast: The White Sox Fire Their Front Office, Injured Rays and Prospect Promotion Time

By | at

The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.

This week, host Darragh McDonald is joined by Steve Adams of MLB Trade Rumors to discuss:

Plus, we answer your questions, including:

  • With the Reds calling up Noelvi Marte, how do they fit in playing time for all their rookie position players? After keeping Nick Senzel at the deadline, what kind of return could they get for trading him during the offseason? (18:40)
  • Will the Mets pursue any notable free agent pitchers this off season? (24:05)
  • Of the teams that have exceeded the base luxury tax threshold this season, which ones do you see as most likely to dip back below it during this coming offseason? (26:15)

Check out our past episodes!

  • Pete Alonso’s Future, Yankees’ Rotation Troubles and Should the Trade Deadline Be Pushed Back? – listen here
  • The Streaking Mariners, the Struggling Angels and Injured Aces – listen here
  • Trade deadline recap – listen here

Shane McClanahan To Undergo Tommy John Surgery

By | at

Rays ace Shane McClanahan will require Tommy John surgery next week, reports Marc Topkin of the Tampa Bay Times (Twitter link). He’s expected to miss the entire 2024 campaign.

It’s a devastating if not entirely unexpected development. The two-time All-Star left his start on August 2 after experiencing forearm discomfort. Tampa Bay has been exploring their options for the past couple weeks, though the club had already confirmed he was expected to miss the remainder of 2023 and that surgery was a consideration. He’s already on the 60-day injured list.

Surprising or not, it’s hard to overstate the significance of losing a pitcher of McClanahan’s caliber. The former first-round draftee debuted with 25 starts of 3.43 ERA ball two seasons ago. By his second major league season, he’d broken through as one of the game’s best pitchers. McClanahan was a legitimate Cy Young contender into August last year before a shoulder impingement cost him a couple weeks.

The absence dropped the South Florida product to sixth in Cy Young balloting, but he still finished his sophomore campaign with a 2.54 ERA through 166 1/3 frames. While his ERA took a bit of a step back this season, a 3.29 mark over 21 starts still ranks 19th among big league starters (minimum 100 innings). He’s 23rd among that same group with a 25.8% strikeout rate. McClanahan earned his second consecutive All-Star nod last month.

Tampa Bay has dealt with a brutal stretch of pitching injuries over the past few months. Top prospect Shane Baz has missed the entire year after undergoing a Tommy John procedure last September. McClanahan becomes the third member of the Rays’ season-opening starting staff to require surgery this year. Jeffrey Springs required a Tommy John procedure in April; Drew Rasmussen underwent flexor tendon surgery last month.

Even after the absences to Baz, Springs and Rasmussen, the Rays had an effective top of the rotation. McClanahan, Tyler Glasnow and Zach Eflin made for an excellent trio. With McClanahan now out of the picture, Glasnow assumes the role of staff ace. Eflin — who has dealt with knee issues throughout his career but has a 3.67 ERA through 23 starts in his first season with Tampa Bay — is the #2 option.

The early-season injuries led the Rays to acquire Aaron Civale from the Guardians at the deadline. That acquisition takes on increased importance with McClanahan out. Still, there’s little recourse beyond internal options for Tampa Bay in patching together the final two rotation spots. Taj Bradley has been up-and-down as a rookie and is on optional assignment to Triple-A. The Rays have pushed Zack Littell into the rotation and recently activated Josh Fleming from the injured list.

Tampa Bay enters play Tuesday three games back of the Orioles in the AL East. They’re still in strong playoff position, 7.5 games clear of the Mariners (the top non-playoff team in the AL). Their chances of running down Baltimore to secure a first-round bye and/or making a deep run once they get into October are obviously dealt a hit by the loss of one of the game’s best starters.

This is the second Tommy John procedure of McClanahan’s career. He missed his freshman year at USF after undergoing surgery in 2016. The Rays figure to be especially cautious with his recovery as a result, although there’s a good chance he would have missed all of ’24 even if this were his first TJS.

McClanahan has just under three years of major league service. He’ll be eligible for arbitration as a Super Two player next offseason. The Rays will need to carry him on their 40-man roster during the offseason but will immediately place him back on the 60-day IL next spring. He’ll collect service time while rehabbing and remains on track to first reach free agency after the 2027 campaign.

Rays Reinstate Josh Fleming, Transfer Shane McClanahan To 60-Day IL

By | at

The Rays have reinstated left-hander Josh Fleming from the 60-day injured list, per Marc Topkin of the Tampa Bay Times. In corresponding moves, right-hander Cooper Criswell was optioned to Triple-A while lefty Shane McClanahan has been transferred to the 60-day IL. McClanahan will now be ineligible to come back until early October, meaning he won’t return in the regular season. Manager Kevin Cash said a few days ago that it was “highly unlikely” McClanahan would return this year.

Fleming, 27, tossed 48 2/3 innings for the Rays earlier this year, allowing 4.62 earned runs per nine frames. He landed on the injured list in early June due to elbow inflammation but has now returned after just over two months. He had previously been working in a multi-inning role, making starts or serving as a bulk pitcher behind an opener. He will likely return to that role, as his four rehab outings were all two innings or longer.

The Rays have a fair amount of rotation uncertainty, with Jeffrey Springs and Drew Rasmussen already out for the year due to elbow surgery. It also seems highly likely that McClanahan could be in that category as well. As mentioned, Cash has said it’s not likely he’ll be back this year, with “everything on the table.” That includes Tommy John surgery, which would put McClanahan’s 2024 season in doubt as well. The path forward hasn’t been confirmed, but this transfer means that the best-case scenario has him returning for the playoffs in October.

The current rotation consists of Tyler Glasnow, Zach Eflin, Aaron Civale and Zack Littell, with Fleming likely factoring in as well, either via traditional starts or bulk outings. All of those guys have fairly significant injury histories, to various degrees, making rotation depth a key focus for the club going forward. Taj Bradley has been optioned to the minors and could be recalled at some point.

The Rays are 70-48 and currently possess the top Wild Card spot in the American League. They will surely be hoping to keep their remaining starters as healthy as possible for the rest of the regular season schedule and a potential postseason push thereafter.

MLB Trade Rumors Podcast: The Streaking Mariners, the Struggling Angels and Injured Aces

By | at

The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.

This week, host Darragh McDonald is joined by Steve Adams of MLB Trade Rumors to discuss:

  • The scorching hot Mariners (2:15)
  • The ice cold Angels (6:20)
  • The Rangers will be without Josh Jung for a while, impacting them and the Rookie of the Year race (8:45)
  • Shane McClanahan could be out for the year and maybe part of 2024 as well (13:15)
  • Yankees put Carlos Rodón back on the injured list (18:35)
  • Red Sox get Trevor Story back (21:35)

Plus, we answer your questions, including:

  • Any chance that the Cubs try to sign Cody Bellinger to a long term deal? (24:35)
  • Of all the players on the Dodgers’ injured list, which will have the most immediate impact both now and for the postseason not named Clayton Kershaw? (30:15)
  • Are the Angels’ manager and general managers jobs respectively in jeopardy if they fail to make the playoffs? (33:25)

Check out our past episodes!

Cash: “Highly Unlikely” Shane McClanahan Returns This Season

By | at

The Rays placed left-hander Shane McClanahan on the 15-day injured list last week due to left forearm tightness. It seems he may be out well beyond those 15 days as manager Kevin Cash tells Marc Topkin of the Tampa Bay Times that surgery is possible and it is “highly unlikely” the southpaw will pitch again this year, though he will see another specialist before that’s confirmed. Cash adds that’s “everything is on the table,” including Tommy John surgery, flexor tendon surgery or the removal of loose bodies, per Topkin.

It’s yet another brutal blow to the Tampa rotation, which has received many this year. The club is already without Drew Rasmussen and Jeffrey Springs, each of whom has undergone season-ending surgery already. Josh Fleming is also on the 60-day injured list alongside those two, having been out since late May.

But the loss of McClanahan would be the most devastating of all, given that he’s been one of the best pitchers in the game in recent years. Dating back to his 2021 debut, he’s tossed 404 2/3 innings, allowing just 3.02 earned runs per nine innings. He’s struck out 28% of batters faced, walked just 7.1% and kept the ball on the ground at a 46.8% clip. He finished seventh in American League Rookie of the Year voting two years ago and then was sixth in Cy Young voting last year.

The mounting pitching injuries have undoubtedly played a role in the club’s slide in the standings. They started out the season with a 13-game winning streak and were in first place in the AL East for much of the season, but have since faded to second. Their 68-46 record has them three games behind the Orioles and four games ahead of the Blue Jays. Now they will seemingly have to navigate the final weeks of the season without their best pitcher.

The current rotation consists of Tyler Glasnow, Zach Eflin, Aaron Civale and Zack Littell, which is a talented group but one with concerns. Glasnow has frequently dealt with injuries in his career, having never reached 112 innings in a major league season. He was scratched from his Sunday start due to back spasms and now will be shut down for two days after receiving an injection, per Topkin. Eflin recently had a knee scare that resulted in him avoiding the injured list, but he’s had knee issues his entire career and it wouldn’t be a surprise to see something flare up again. Civale also has a spotty health history, which has prevented him from ever hitting 125 innings in a big league campaign. Littell has primarily been a reliever and has only recently begun stretching out to a starter’s workload.

With the trade deadline now in the rear-view mirror, the Rays will have limited options to supplement this group. Fleming is on a rehab assignment and could come back shortly, though he has a career ERA of 4.86 around multiple IL stints of his own. Prospect Taj Bradley could be recalled from the minors, though his first 16 major league starts resulted in a 5.67 ERA. The Rays could also try to acquire players from outside the organization, though those will naturally be flawed options in one way or another.

The concerns with McClanahan will seemingly extend beyond the current playoff race, given the serious options that are on the table. If Tommy John surgery is ultimately required, that would likely wipe out his entire 2024 season as well, given that recovery usually takes at least 14 months after that procedure. That would be his second such surgery, as he underwent TJS back in 2015, prior to being drafted. The time off after flexor tendon surgery tends to be a little lighter but can still run close to a year.

McClanahan is currently 26 years old and will finish this season with his service time count at two years and 158 days. He’ll be a lock to qualify for arbitration as a Super Two player this winter, the first of four arb seasons before he’s slated for free agency after 2027. It’s possible that he ends up missing the entirety of his age-27 season, though he and the Rays will obviously be hoping that’s not the case.

Rays Place Shane McClanahan On Injured List

By | at

6:40pm: Tampa Bay has officially placed McClanahan on the IL, Topkin tweets. The club said they are “in the process of gathering further information” and will provide updates when they become available.

6:13pm: The Rays plan to place Shane McClanahan on the 15-day injured list, tweets Marc Topkin of the Tampa Bay Times. The two-time All-Star felt some soreness on the outside of his forearm during yesterday’s start against the Yankees.

Tampa Bay sent McClanahan for imaging this morning. Topkin that the Rays still don’t have a set diagnosis from initial testing. The 6’1″ left-hander is slated for further evaluation in the coming days but will need at least two weeks on the shelf.

Until there’s more clarity on the issue, the overall timetable remains unknown. Yet even a best-case scenario for the Rays sees them lose arguably their best pitcher for a couple weeks while they battle for a division title. Tampa Bay has gone 26-27 since the start of June, a couple months of average play after their league-best performance through May. As a result, they’ve dropped two games back of the Orioles in the AL East.

They’re still in great shape to secure a playoff spot. The Rays sit three games clear of the second-best Wild Card team and 7.5 up on the top non-playoff club. They’ll need to track down Baltimore to snag a first-round bye, though, and any extended absence from McClanahan would only make that more challenging.

The 26-year-old was on a Cy Young pace last year before a late-season shoulder impingement knocked him to sixth in the voting. He hasn’t been quite as good this season but remains one of the top pitchers in the sport. Through 115 innings, McClanahan carries a 3.29 ERA with a strong 25.8% strikeout rate. He missed a couple weeks earlier in the season with back tightness but returned not long after a minimal stay on the shelf.

Pitching injuries have been an all too familiar occurrence for Tampa Bay this year. The Rays were without Tyler Glasnow early and lost Jeffrey Springs and Drew Rasmussen to season-ending surgeries midway through the season. They dealt top first base prospect Kyle Manzardo to Cleveland for Aaron Civale to fortify the starting staff. That acquisition could take on even more importance if McClanahan misses a notable chunk of time. Tampa Bay optioned rookie Taj Bradley to Triple-A after acquiring Civale; he’d seem the likeliest candidate for a recall to take McClanahan’s active roster spot.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top